Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 12/20 | 0.55 |
| ▸ | RARG | P13631 | 12/20 | 0.55 |
| ▸ | RARA | P10276 | 10/20 | 0.55 |
| ▸ | RXRA | P19793 | 12/20 | 0.44 |
| ▸ | HNF4A | P41235 | 2/20 | 0.44 |
| ▸ | RXRB | P28702 | 4/20 | 0.44 |
| ▸ | RXRG | P48443 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9119993 | 0.88 | RARA (0.46) | RARBRARGRARARXRAHNF4A | |
| SCHEMBL9051345 | 0.82 | RARB (0.63) | RARBRARGRARARXRARXRB | |
| SCHEMBL9118198 | 0.78 | RARB (0.60) | RARBRARGRARARXRAHNF4A | |
| SCHEMBL9049859 | 0.77 | RARB (0.66) | RARBRARGRARARXRARXRB | |
| SCHEMBL9050626 | 0.77 | RARB (0.69) | RARBRARGRARARXRARXRB | |
| SCHEMBL9054209 | 0.77 | RARG (0.69) | RARBRARGRARARXRARXRB | |
| SCHEMBL9049761 | 0.77 | RARB (0.69) | RARBRARGRARARXRARXRB | |
| SCHEMBL4192048 | 0.76 | RARB (0.67) | RARBRARGRARARXRARXRB | |
| SCHEMBL9050596 | 0.75 | RARB (0.47) | RARBRARGRARARXRAHNF4A | |
| SCHEMBL9048881 | 0.74 | RARB (0.66) | RARBRARGRARARXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0874626-B1 | USE OF INHIBITORS OF RETINOIC ACID ACTIVITY FOR WOUND HEALING | CT INTERNAT DERECH S DERMATOLO (FR) | 2004-12-29 | — | — | EP | claimed |
| EP-0892633-B1 | USE OF INHIBITORS OF THE ACTIVITY OF RETINOIC ACID FOR TREATING SENSITIVE SKIN AND/OR ACUTE DAMAGE INDUCED BY UV RADIATION | GALDERMA RECH DERMATOLOGIQUE (FR) | 2003-03-05 | — | — | EP | claimed |
| US-6248749-B1 | TOPICALLY APPLYING RETINOID ANTAGONIST TO SENSITIVE SKIN TO TREAT ALLERGIES/SUNBURN | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2001-06-19 | — | — | US | claimed |
| US-5973007-A | SURGERY, TRAUMA WOUNDS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1999-10-26 | — | — | US | claimed |
| US-20020137794-A1 | Retinoic acid receptor (RAR) agonists, agonists for steroid/thyroid hormone receptor superfamily, and an agonist for a heterodimer partner | SALK INSTITUTE FOR BIOLOGICAL STUDIES, THE | 2002-09-26 | — | — | US | disclosed |
| US-6436993-B1 | SYNERGISTIC MIXTURES OF RETINOIC ACID RECEPTOR (RAR) ANTAGONISTS AND STEROID, THYROID OR RETINOID RECEPTOR AGONISTS SUCH AS PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS USED TO CONTROL CELLULAR PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2002-08-20 | — | — | US | disclosed |
| US-6248749-B1 | TOPICALLY APPLYING RETINOID ANTAGONIST TO SENSITIVE SKIN TO TREAT ALLERGIES/SUNBURN | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 2001-06-19 | — | — | US | disclosed |
| WO-2001003659-A1 | USE OF RAR ANTAGONISTS AS MODULATORS OF HORMONE MEDIATED PROCESSES | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2001-01-18 | — | — | WO | disclosed |
| US-5973007-A | SURGERY, TRAUMA WOUNDS | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (FR) | 1999-10-26 | — | — | US | disclosed |
| WO-1995033745-A9 | NOVEL COMPOUNDS USEFUL IN MODULATING GENE EXPRESSION OF RETINOID RESPONSIVE GENES AND/OR HAVING ANTI-AP-1 ACTIVITY | — | 1996-01-18 | — | — | WO | disclosed |
| WO-1995033745-A2 | NOVEL COMPOUNDS USEFUL IN MODULATING GENE EXPRESSION OF RETINOID RESPONSIVE GENES AND/OR HAVING ANTI-AP-1 ACTIVITY | SRI INTERNATIONAL (US) | 1995-12-14 | — | — | WO | disclosed |